(Q30842527)

27 June 2017

title

Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing (English)

1 reference

ORCID Public Data File 2021

27 June 2017

1 reference

1 reference

1 reference

author name string

Takamizawa S

1

1 reference

27 June 2017

Okamoto S

2

1 reference

27 June 2017

Wen J

3

1 reference

27 June 2017

Bishop W

4

1 reference

27 June 2017

Kimura K

5

1 reference

27 June 2017

Sandler A

6

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Journal of Pediatric Surgery

27 June 2017

published in

1 reference

27 June 2017

volume

35

1 reference

27 June 2017

issue

2

1 reference

27 June 2017

page(s)

375-379

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

27 June 2017

1 reference

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

A role for CD95 ligand in preventing graft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Antitumor effect of locally produced CD95 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Overexpression of Fas ligand does not confer immune privilege to a pancreatic beta tumor cell line (betaTC-3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

Fas and Fas ligand: a death factor and its receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2800%2990044-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3468(00)90044-7

1 reference

27 June 2017

1 reference